Quest Pharmaceutical Services questpharm.com


Public lists: Pharma Startups (4732)

QPS merged in 2008 with First Analysis portfolio company Bio-Kinetic Clinical Applications, a drug development services company that designs and conducts Phase I clinical studies for branded pharmaceutical, biotechnology, and generic drug companies. QPS is a independent, GLP-compliant contract laboratory supporting drug discovery and development for branded pharmaceutical, biotechnology, and generic drug companies.

QPS merged in 2008 with First Analysis portfolio company Bio-Kinetic Clinical Applications, a drug development services company that designs and conducts Phase I clinical studies for branded pharmaceutical, biotechnology, and generic drug companies. ...Show all

Company (Alive / Active)

Phone:

Fax:

1 Innovation Way Newark, DE 19739
Newark, 19711
Delaware, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Quest Pharmaceutical Services $0M Nov 30, 2018
See all 21 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Quest Pharmaceutical Services Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Immunetrics

Pittsburgh, Pennsylvania, United States
Alive / ActiveNobody prototypes a jet plane or car without running the empirical data through a computer model. A clinical trial is also a prototype. Now, pharmaceutical companies can simulate as many scenarios as necessary to optimize success in the final design of their clinical trials.nBiosimulation technology from Immunetrics Inc. aims to provide a bridge from research and experiment to trial design. Immunetrics' toolset aims to provide predictive computer models based on biological mechanisms. The inputs...Show allLogin to see details

NeuroGenomeX

Madison, Wisconsin, United States
Alive / ActiveNeuroGenomeX is a drug discovery company developing novel treatments for diseases of the brain and nervous system. The current NeuroGenomeX discovery program is focused on therapeutic target areas of epilepsy and traumatic brain injury. NeuroGenomeX is advancing its lead drug candidate, 2-deoxy-D-glucose (2DG), as an anticonvulsant that stops seizures and has beneficial effects against adverse long-term consequences of epilepsy. 2DG also has shown favorable therapeutic neuroprotective effects in...Show allLogin to see details
See all 21 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)